LentiRILES, a miRNA-ON sensor system for monitoring the functionality of miRNA in cancer biology and therapy.
Animals
Apoptosis
Biomarkers, Tumor
/ genetics
Biosensing Techniques
/ methods
Cell Cycle
Cell Movement
Cell Proliferation
Female
Gene Expression Regulation, Neoplastic
Genes, Reporter
Glioblastoma
/ genetics
Humans
Lentivirus
/ genetics
Luminescent Measurements
Male
Mice
Mice, SCID
MicroRNAs
/ analysis
Middle Aged
Tumor Cells, Cultured
RILES
RNA therapeutics
glioblastoma
miRNA
molecular imaging
Journal
RNA biology
ISSN: 1555-8584
Titre abrégé: RNA Biol
Pays: United States
ID NLM: 101235328
Informations de publication
Date de publication:
15 10 2021
15 10 2021
Historique:
pubmed:
28
9
2021
medline:
26
2
2022
entrez:
27
9
2021
Statut:
ppublish
Résumé
A major unresolved challenge in miRNA biology is the capacity to monitor the spatiotemporal activity of miRNAs expressed in animal disease models. We recently reported that the miRNA-ON monitoring system called RILES (RNAi-inducible expression Luciferase system) implanted in lentivirus expression system (LentiRILES) offers unique opportunity to decipher the kinetics of miRNA activity
Identifiants
pubmed: 34570661
doi: 10.1080/15476286.2021.1978202
pmc: PMC8682973
doi:
Substances chimiques
Biomarkers, Tumor
0
MIRN200 microRNA, human
0
MicroRNAs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
198-214Références
Oncotarget. 2017 Jul 03;8(39):65457-65468
pubmed: 29029445
PLoS One. 2011;6(8):e23734
pubmed: 21876765
J Biol Chem. 2014 Sep 5;289(36):25079-87
pubmed: 25059666
J Nucl Med. 2008 Oct;49(10):1686-93
pubmed: 18794255
Cancer Res. 2010 Aug 15;70(16):6401-6
pubmed: 20663901
J Mol Med (Berl). 2016 Jun;94(6):629-44
pubmed: 27094812
J Control Release. 2016 Jun 28;232:103-12
pubmed: 27063424
Nanomedicine (Lond). 2015;10(21):3249-60
pubmed: 26470837
BMC Genomics. 2009 Sep 04;10:413
pubmed: 19732433
J Control Release. 2020 Nov 10;327:429-443
pubmed: 32853728
Cancer Manag Res. 2019 Feb 25;11:1843-1855
pubmed: 30881112
BMC Genomics. 2013 Apr 18;14:264
pubmed: 23597149
Genes Dev. 2003 Apr 15;17(8):991-1008
pubmed: 12672692
Dev Biol. 2007 Feb 1;302(1):1-12
pubmed: 16989803
Int J Pharm. 2014 Jan 2;460(1-2):264-72
pubmed: 24225347
Nucleic Acids Res. 2009 May;37(9):2867-81
pubmed: 19282453
Dev Biol. 2010 Dec 15;348(2):210-21
pubmed: 20937268
Nature. 2000 Feb 24;403(6772):901-6
pubmed: 10706289
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
pubmed: 28209991
Nucleic Acids Res. 2013 Mar 1;41(5):2817-31
pubmed: 23335783
Theranostics. 2017 Oct 12;7(18):4517-4536
pubmed: 29158842
J Control Release. 2015 Mar 10;201:78-89
pubmed: 25526702
Cancers (Basel). 2015 Dec 18;7(4):2466-85
pubmed: 26694467
Breast Cancer Res. 2010;12(5):210
pubmed: 21067538
Neurotherapeutics. 2017 Apr;14(2):358-371
pubmed: 28299724
Biomaterials. 2011 Mar;32(7):1915-22
pubmed: 21122913
Curr Drug Targets. 2015;16(12):1381-403
pubmed: 25808651
Dev Biol. 2013 Feb 1;374(1):223-33
pubmed: 23201578
Cancer Lett. 2014 Mar 28;344(2):166-73
pubmed: 24262661
Carcinogenesis. 2007 Jan;28(1):2-12
pubmed: 17028302
Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):527-41
pubmed: 19394373
Dev Biol. 2003 Jul 15;259(2):364-79
pubmed: 12871707
Tumour Biol. 2016 Sep;37(9):11667-11677
pubmed: 27438705
Cell. 2012 Apr 27;149(3):515-24
pubmed: 22541426
Microrna. 2015;4(2):131-45
pubmed: 26456536
Cell. 1993 Dec 3;75(5):855-62
pubmed: 8252622
J Adv Res. 2020 Apr 29;24:317-324
pubmed: 32455006
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Nat Rev Cancer. 2010 May;10(5):319-31
pubmed: 20414201
PLoS One. 2012;7(12):e51952
pubmed: 23251659
PLoS One. 2017 May 11;12(5):e0177492
pubmed: 28493972
Nucleic Acids Res. 2019 Aug 22;47(14):7321-7332
pubmed: 31214713
Cell. 2001 Jul 13;106(1):23-34
pubmed: 11461699
Genes Dev. 2015 Mar 1;29(5):538-54
pubmed: 25737282
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Development. 2017 Aug 1;144(15):2719-2729
pubmed: 28765213
Mol Ther. 2013 May;21(5):934-46
pubmed: 23439497
Nat Biotechnol. 2018 Oct 11;36(10):909-910
pubmed: 30307922
Nat Rev Mol Cell Biol. 2007 Jan;8(1):23-36
pubmed: 17183358
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Nucleic Acids Res. 2013 Nov;41(20):e192
pubmed: 24013565
Adv Drug Deliv Rev. 2016 Sep 1;104:2-15
pubmed: 27259398
Nat Rev Drug Discov. 2019 Jun;18(6):421-446
pubmed: 30846871
Nat Rev Genet. 2011 Feb;12(2):99-110
pubmed: 21245828
Curr Opin Genet Dev. 2012 Aug;22(4):368-73
pubmed: 22578317
Nature. 2003 Sep 25;425(6956):415-9
pubmed: 14508493
EMBO J. 2012 Dec 12;31(24):4511-23
pubmed: 23160410
Nature. 2010 Jan 14;463(7278):237-40
pubmed: 20075919
Curr Opin Biomed Eng. 2017 Dec;4:1-12
pubmed: 29333521
Part Fibre Toxicol. 2017 Jun 24;14(1):22
pubmed: 28646905
BMC Med Res Methodol. 2017 Jun 2;17(1):84
pubmed: 28577540
J Biol Chem. 2017 Jan 13;292(2):611-628
pubmed: 27909058
Nanomedicine. 2014 Aug;10(6):1131-7
pubmed: 24823644
Methods Mol Biol. 2016;1372:193-208
pubmed: 26530925
Theranostics. 2017 Apr 10;7(6):1663-1673
pubmed: 28529643
Mol Biotechnol. 2013 Mar;53(3):308-14
pubmed: 22407723
Nat Rev Genet. 2011 Feb;12(2):136-49
pubmed: 21245830
PLoS Genet. 2010 Mar 05;6(3):e1000869
pubmed: 20221260
RNA. 2004 Dec;10(12):1957-66
pubmed: 15525708
Oncol Rep. 2014 Apr;31(4):1509-16
pubmed: 24573597
Nat Genet. 2006 Feb;38(2):228-33
pubmed: 16380711
J Clin Oncol. 2006 Jun 1;24(16):2563-9
pubmed: 16735709
Curr Med Chem. 2013;20(29):3594-603
pubmed: 23745564
OMICS. 2018 Jan;22(1):17-34
pubmed: 29356626
Blood. 2006 Dec 1;108(12):3646-53
pubmed: 16882713
Oncotarget. 2017 Sep 23;8(49):85783-85793
pubmed: 29156756
Nat Rev Genet. 2015 Jul;16(7):421-33
pubmed: 26077373
Science. 2001 Aug 3;293(5531):834-8
pubmed: 11452083
Nucleic Acids Res. 2012 Jan;40(2):e13
pubmed: 22110035